TELADOC HEALTH, INC. Restructuring Costs
TELADOC HEALTH, INC. (TDOC) reported Restructuring Costs of $904.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-07-30
- TELADOC HEALTH, INC. restructuring costs for the quarter ending 2026-06-30 was $904.00K, a 84.12% decline year-over-year.
- TELADOC HEALTH, INC. restructuring costs for the quarter ending 2026-03-31 was $11.97M, a 175.48% increase year-over-year.
- TELADOC HEALTH, INC. restructuring costs for the quarter ending 2025-12-31 was $6.80M, a 21.31% increase year-over-year.
- TELADOC HEALTH, INC. restructuring costs for the quarter ending 2025-09-30 was $1.95M, a 45.53% decline year-over-year.
- TELADOC HEALTH, INC. restructuring costs for fiscal 2025 was $18.79M, a 7.71% decline from fiscal 2024.
- TELADOC HEALTH, INC. restructuring costs for fiscal 2024 was $20.36M, a 20.15% increase from fiscal 2023.
- TELADOC HEALTH, INC. restructuring costs for fiscal 2023 was $16.94M, a 128.45% increase from fiscal 2022.
- TELADOC HEALTH, INC. restructuring costs for fiscal 2022 was $7.42M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $904.00K 10-Q · filed 2026-07-30 | $12.88M 10-Q · filed 2026-07-30 | $19.68M derived: sum of 3 quarters · filed 2026-07-30 | $21.63M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $11.97M 10-Q · filed 2026-04-30 | $18.77M derived: sum of 2 quarters · filed 2026-04-30 | $20.72M derived: sum of 3 quarters · filed 2026-04-30 | $26.41M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.75M derived: sum of 2 quarters · filed 2026-02-26 | $14.44M derived: sum of 3 quarters · filed 2026-07-30 | $18.79M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.95M 10-Q · filed 2025-10-30 | $7.64M derived: sum of 2 quarters · filed 2026-07-30 | $11.99M 10-Q · filed 2025-10-30 | $17.59M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $5.69M 10-Q · filed 2026-07-30 | $10.04M 10-Q · filed 2026-07-30 | $15.64M derived: sum of 3 quarters · filed 2026-07-30 | $19.22M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $4.35M 10-Q · filed 2026-04-30 | $9.95M derived: sum of 2 quarters · filed 2026-04-30 | $13.53M derived: sum of 3 quarters · filed 2026-04-30 | $15.03M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.18M derived: sum of 2 quarters · filed 2026-02-26 | $10.68M derived: sum of 3 quarters · filed 2026-02-26 | $20.36M 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.58M 10-Q · filed 2025-10-30 | $5.08M derived: sum of 2 quarters · filed 2025-10-30 | $14.75M 10-Q · filed 2025-10-30 | $15.65M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.50M 10-Q · filed 2025-07-30 | $11.17M 10-Q · filed 2025-07-30 | $12.07M derived: sum of 3 quarters · filed 2026-02-26 | $12.48M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $9.67M 10-Q · filed 2025-05-01 | $10.57M derived: sum of 2 quarters · filed 2026-02-26 | $10.98M derived: sum of 3 quarters · filed 2026-02-26 | $18.51M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $899.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.31M derived: sum of 2 quarters · filed 2026-02-26 | $8.84M derived: sum of 3 quarters · filed 2026-02-26 | $16.94M 10-K · filed 2026-02-26 |
| 2023-09-30 | $411.00K 10-Q · filed 2024-10-31 | $7.94M derived: sum of 2 quarters · filed 2024-10-31 | $16.04M 10-Q · filed 2024-10-31 | $19.78M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $7.53M 10-Q · filed 2024-08-01 | $15.63M 10-Q · filed 2024-08-01 | $19.37M derived: sum of 3 quarters · filed 2025-02-27 | $23.05M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $8.10M 10-Q · filed 2024-04-26 | $11.84M derived: sum of 2 quarters · filed 2025-02-27 | $15.52M derived: sum of 3 quarters · filed 2025-02-27 | $15.52M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $3.74M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $7.42M derived: sum of 2 quarters · filed 2025-02-27 | $7.42M derived: sum of 3 quarters · filed 2025-02-27 | $7.42M 10-K · filed 2025-02-27 |
| 2022-09-30 | $3.68M 10-Q · filed 2023-10-27 | $3.68M derived: sum of 2 quarters · filed 2023-10-27 | $3.68M 10-Q · filed 2023-10-27 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-07-28 | $0.00 10-Q · filed 2023-07-28 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-23 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |